The Novel Heterocyclic Trioxirane [(1,3,5-Tris Oxiran-2-yl)Methyl)-1,3,5-Triazinane-2,4,6-Trione (TATT)] Exhibits a Better Anticancer Effect than Platinum-Based Chemotherapy by Induction of Apoptosis and Curcumin Further Enhances its Chemosensitivity
Chun Li Su*, Ying Ti Wang, Mu Hsin Chang, Kang Fang, Kwunmin Chen
*此作品的通信作者
研究成果: 雜誌貢獻 › 期刊論文 › 同行評審
5
引文
斯高帕斯(Scopus)